Celularity Inc.CELUNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank29
3Y CAGR+43.7%
5Y CAGR-15.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+43.7%/yr
vs +1114.8%/yr prior
5Y CAGR
-15.1%/yr
Recent acceleration
Acceleration
-1071.1pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $70.95M | -8.6% |
| 2024 | $77.59M | -61.0% |
| 2023 | $199.04M | +732.5% |
| 2022 | $23.91M | -80.2% |
| 2021 | $120.74M | -25.1% |
| 2020 | $161.27M | -42.2% |
| 2019 | $278.95M | +25405364.5% |
| 2018 | $1098.00 | - |